Sign in Subscribe

Clinical trials

Clinical trials

Breakthrough in OBGYN and Reproduction Research: Scientists Discover Promising Treatment for HPV Clearance

Recent study results published in Scientific Reports have provided encouraging insights into the potential efficacy of a novel treatment for human papillomavirus (HPV) clearance and cervical microbiota shift. Researchers conducted a prospective, multi-center, randomized, placebo-controlled trial involving 62 women newly diagnosed with HPV infection without visible cervical lesions. The oral

Clinical trials

Breakthrough in OBGYN and Reproduction Research: Scientists Discover Promising Treatment for HPV Clearance

Recent study results published in Scientific Reports have provided encouraging insights into the potential efficacy of a novel treatment for human papillomavirus (HPV) clearance and cervical microbiota shift. Researchers conducted a prospective, multi-center, randomized, placebo-controlled trial involving 62 women newly diagnosed with HPV infection without visible cervical lesions. The oral

Clinical trials

Long-term Clinical Outcomes With Tisagenlecleucel in High-risk Relapsed/refractory Follicular Lymphoma

A new study published in the Haematologica journal provides four-year follow-up results on the efficacy, safety, and pharmacokinetics of tisagenlecleucel treatment for patients with relapsed/refractory follicular lymphoma. The study, led by researchers from the University Teaching Hospital, demonstrates robust and durable responses with tisagenlecleucel and a favorable safety profile,

Clinical trials

Long-term Clinical Outcomes With Tisagenlecleucel in High-risk Relapsed/refractory Follicular Lymphoma

A new study published in the Haematologica journal provides four-year follow-up results on the efficacy, safety, and pharmacokinetics of tisagenlecleucel treatment for patients with relapsed/refractory follicular lymphoma. The study, led by researchers from the University Teaching Hospital, demonstrates robust and durable responses with tisagenlecleucel and a favorable safety profile,

T cells

Long-term Clinical Outcomes With Tisagenlecleucel in High-risk Relapsed/refractory Follicular Lymphoma

A new study published in the Haematologica journal provides four-year follow-up results on the efficacy, safety, and pharmacokinetics of tisagenlecleucel treatment for patients with relapsed/refractory follicular lymphoma. The study, led by researchers from the University Teaching Hospital, demonstrates robust and durable responses with tisagenlecleucel and a favorable safety profile,

Clinical trials

Transfusion of Pathogen-Reduced Red Blood Cells Yields Noninferior Outcomes for Acute Kidney Injury in Cardiac Surgery Patients

Researchers from Yale University School of Medicine have conducted a phase 3 trial to investigate the safety and efficacy of transfusing amustaline/glutathione pathogen-reduced red blood cells in cardiac surgery patients with increased risk of red cell transfusion. The trial, which randomized 581 subjects, found that transfusion of pathogen-reduced red

Clinical trials

Efficacy of Brief CBT Text Message Intervention for Co-occurring PTSD Symptoms and Alcohol Misuse

Current study results on a randomized controlled trial evaluating a brief, self-directed cognitive behavioral therapy-based (CBT) text message intervention for individuals with PTSD symptoms and co-occurring alcohol misuse (PTSD + AM) have been published. The trial aimed to refine the intervention by testing whether evidence-based techniques from cognitive psychology (message framing)

Clinical trials

Efficacy of Brief CBT Text Message Intervention for Co-occurring PTSD Symptoms and Alcohol Misuse

Current study results on a randomized controlled trial evaluating a brief, self-directed cognitive behavioral therapy-based (CBT) text message intervention for individuals with PTSD symptoms and co-occurring alcohol misuse (PTSD + AM) have been published. The trial aimed to refine the intervention by testing whether evidence-based techniques from cognitive psychology (message framing)
See all